Showing results (21-30 of 105) with videos related to
Sort By:
Pageof 11
The Journal of Urology|November 11, 2005
Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancerDan Leibovici, Ashish M Kamat, Curtis A Pettaway, et al.Proceedings of the National Academy of Sciences of the United States of America|September 27, 2008
CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patientsChrysoula I Liakou, Ashish Kamat, Derek Ng Tang, et al.Cell & Bioscience|October 14, 2014
Posttranslational regulation of Akt in human cancerChia-Hsin Chan, Ukhyun Jo, Abraham Kohrman, et al.BMC Genomics|March 25, 2014
How to get the most from microarray data: advice from reverse genomicsIvan P Gorlov, Ji-Yeon Yang, Jinyoung Byun, et al.Journal of the National Cancer Institute|November 1, 2007
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimensPeter F Thall, Christopher Logothetis, Lance C Pagliaro, et al.Oncogene|September 29, 2021
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuelEstefania Labanca, Juan Bizzotto, Pablo Sanchis, et al.Medicine|September 13, 2021
The protein arginine methyltransferases (PRMTs) PRMT1 and CARM1 as candidate epigenetic drivers in prostate cancer progressionIoanna Maria Grypari, Souzana Logotheti, Vasiliki Zolota, et al.Applied Bioinformatics|May 8, 2004
TAD: a web interface and database for tissue microarraysKevin R Coombes, Lin Zhang, Carlos Bueso-Ramos, et al.Cancers|January 23, 2020
Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate CancerFilippos Koinis, Paul Corn, Nila Parikh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancerPaul Mathew, Peter F Thall, Donnah Jones, et al.Pageof 11